Pharmaceutical Technology and Biopharmacy

University of Groningen > Faculty of Science and Engineering > Faculty Board FSE > FSE Research > Groningen Research Institute of Pharmacy > Pharmaceutical Technology and Biopharmacy

Contact information

A Deusinglaan
1
Groningen
9713 AV
Netherlands
  • Phone: +31 50 363 3284
  • Fax: +31 50 363 2500
Publications
  1. Characterization and Formulation of Isoniazid for High-Dose Dry Powder Inhalation

    Sibum, I., Hagedoorn, P., Frijlink, H. W. & Grasmeijer, F., 13-May-2019, In : Pharmaceutics. 11, 5, 15 p., 233.

    Research output: Contribution to journalArticleAcademicpeer-review

  2. PH-CONTROLLED PULSATILE DELIVERY SYSTEM, METHODS FOR PREPARATION AND USE THEREOF

    Schellekens, R. C. A. & Frijlink, H. W., 1-Feb-2007, IPC No. A61K 47/ 30 A I, Patent No. WO2007013794, Priority date 29-Jul-2005, Priority No. WO2005NL00559

    Research output: PatentProfessional

  3. DRUG DELIVERY SYSTEM

    Bloemers, J. M. M., Eissens, A. C., Frijlink, H. W. & De Leede, L. G. J., 22-Nov-2012, IPC No. A61K 31/ 568 A I, Patent No. WO2012158030, Priority date 3-Oct-2011, Priority No. EP20110183732

    Research output: PatentProfessional

  4. NICOTINAMIDE COMPOSITIONS AND THE THERAPEUTIC USE THEREOF

    Meijerink, H. J. C., Changoer, L., Blom, W., Visser, M. R., Frijlink, H. W. & Eissens, A. C., 17-Jan-2013, IPC No. A61P 25/ 14 A I, Patent No. WO2013009186, Priority date 14-Jul-2011, Priority No. EP20110173963

    Research output: PatentProfessional

  5. Ovalbumin-containing core-shell implants suitable to obtain a delayed IgG1 antibody response in support of a biphasic pulsatile release profile in mice

    Amssoms, K., Born, P. A., Beugeling, M., De Clerck, B., Van Gulck, E., Hinrichs, W. L. J., Frijlink, H. W., Grasmeijer, N., Kraus, G., Sutmuller, R., Simmen, K. & Baert, L., 1-Aug-2018, In : PLoS ONE. 13, 8

    Research output: Contribution to journalArticleAcademicpeer-review

View all (632) »

Datasets
  1. Dataset: Ovalbumin-containing core-shell implants suitable to obtain a delayed IgG1 antibody response in support of a biphasic pulsatile release profile in mice

    Amssoms, K. (Creator), Born, P. (Creator), Beugeling, M. (Creator), De Clerck, B. (Creator), Van Gulck, E. (Creator), Hinrichs, W. (Creator), Frijlink, E. (Creator), Grasmeijer, N. (Creator), Kraus, G. (Creator), Sutmuller, R. (Creator), Simmen, K. (Creator), Baert, L. (Creator), University of Groningen, 17-Aug-2018

    Dataset

View all (1) »

Prizes
  1. Astellas Foundation 2008-2009

    Erik Frijlink (Recipient), 2008

    PrizeAcademic

  2. Wubbo Ockels Price

    Anne Boer, de (Recipient), 2010

    PrizeAcademic

View all (4) »

Activities
  1. International Severe Asthma Forum (ISAF)

    Paul Hagedoorn (Invited speaker)
    10-Nov-2018

    Activity: Participating in or organising an eventParticipation in conferenceAcademic

  2. 2nd AZ Respiratory Summit & 5th Asia Respiratory Leadership Forum

    Paul Hagedoorn (Invited speaker)
    31-Mar-2018Apr-2018

    Activity: Participating in or organising an eventParticipation in conferenceAcademic

  3. KL Pharmacy Conference 2018

    Paul Hagedoorn (Speaker)
    31-Mar-2018

    Activity: Participating in or organising an eventParticipation in conferenceAcademic

View all (15) »

Press / Media
  1. UMCG werkt aan vaccin om alle griepen de wereld uit te helpen

    Sonja Graver

    08/03/2018

    1 media contribution

    Press/Media: ResearchPopular

  2. Griepgolf houdt aan. Hoe ontkomen we aan de griep?

    Sonja Graver

    02/03/2018

    1 media contribution

    Press/Media: Expert CommentPopular

  3. "De kennis van nu" interview on national television 09-11-2017

    Erik Frijlink

    09/11/2017

    1 media contribution

    Press/Media: ResearchPopular

View all (8) »

View graph of relations

ID: 32615